Gastrointestinal discomfort(GD)is a disorder that affects 40%of the adult population worldwide. MUCOSAVE™ is a clinically proven ingredient that helps to counteract the symptoms associated with GatroEsophageal Reflux Disease(GERD)and improves the quality of life of people affected by GD.In addition, preliminary clinical data support the prebiotic activity of MUCOSAVE™,which is able to modulate the gut microbiota either by direct growth stimulation of beneficial gut bacteria and through antimicrobial effects on bacterial pathogens thus balancing the gut microbiota in people suffering from GD.
